APO RESEARCH · REPORT
Apomorphine Hydrochloride
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Product & engineering
Understand the product.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Selected research
Market Analysis & Forecast
Global Apomorphine Hydrochloride Market Analysis and Forecast 2026-2032
Market perspective
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025.
Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%.
Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report presents an overview of global market for Apomorphine Hydrochloride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Apomorphine Hydrochloride, also provides the sales of main regions and countries. Of the upcoming market potential for Apomorphine Hydrochloride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Apomorphine Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Apomorphine Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Apomorphine Hydrochloride sales, projected growth trends, production technology, application and end-user industry.
Apomorphine Hydrochloride Segment by Company
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Tianjin Tianwei Pharmaceutical
Sunovion
Apomorphine Hydrochloride Segment by Type
Injection
Tablets
Thinfilm
Nasal Powder (Pipeline)
Apomorphine Hydrochloride Segment by Application
Parkinson Disease
Erectile Dysfunction
Apomorphine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apomorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apomorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apomorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Apomorphine Hydrochloride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Apomorphine Hydrochloride sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablets
- Thinfilm
- Nasal Powder (Pipeline)
Applications
- Parkinson Disease
- Erectile Dysfunction
Companies covered
- Supernus Pharmaceuticals
- Britannia Pharmaceuticals STADA
- Ever Pharma
- Evolan Pharma AB (PharmSwed)
- Tianjin Tianwei Pharmaceutical
- Sunovion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Apomorphine Hydrochloride Market by Type
- 1.2.1 Global Apomorphine Hydrochloride Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injection
- 1.2.3 Tablets
- 1.2.4 Thinfilm
- 1.2.5 Nasal Powder (Pipeline)
- 1.3 Apomorphine Hydrochloride Market by Application
- 1.3.1 Global Apomorphine Hydrochloride Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Parkinson Disease
- 1.3.3 Erectile Dysfunction
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Apomorphine Hydrochloride Market Dynamics
- 2.1 Apomorphine Hydrochloride Industry Trends
- 2.2 Apomorphine Hydrochloride Industry Drivers
- 2.3 Apomorphine Hydrochloride Industry Opportunities and Challenges
- 2.4 Apomorphine Hydrochloride Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Apomorphine Hydrochloride Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Apomorphine Hydrochloride Revenue by Region
- 3.2.1 Global Apomorphine Hydrochloride Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Apomorphine Hydrochloride Revenue by Region (2021-2026)
- 3.2.3 Global Apomorphine Hydrochloride Revenue by Region (2027-2032)
- 3.2.4 Global Apomorphine Hydrochloride Revenue Market Share by Region (2021-2032)
- 3.3 Global Apomorphine Hydrochloride Sales Estimates and Forecasts 2021-2032
- 3.4 Global Apomorphine Hydrochloride Sales by Region
- 3.4.1 Global Apomorphine Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Apomorphine Hydrochloride Sales by Region (2021-2026)
- 3.4.3 Global Apomorphine Hydrochloride Sales by Region (2027-2032)
- 3.4.4 Global Apomorphine Hydrochloride Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Apomorphine Hydrochloride Revenue by Manufacturers
- 4.1.1 Global Apomorphine Hydrochloride Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Apomorphine Hydrochloride Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Apomorphine Hydrochloride Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Apomorphine Hydrochloride Sales by Manufacturers
- 4.2.1 Global Apomorphine Hydrochloride Sales by Manufacturers (2021-2026)
- 4.2.2 Global Apomorphine Hydrochloride Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Apomorphine Hydrochloride Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Apomorphine Hydrochloride Sales Price by Manufacturers (2021-2026)
- 4.4 Global Apomorphine Hydrochloride Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Apomorphine Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Apomorphine Hydrochloride Manufacturers, Product Type & Application
- 4.7 Global Apomorphine Hydrochloride Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Apomorphine Hydrochloride Market CR5 and HHI
- 4.8.2 2025 Apomorphine Hydrochloride Tier 1, Tier 2, and Tier 3
5 Apomorphine Hydrochloride Market by Type
- 5.1 Global Apomorphine Hydrochloride Revenue by Type
- 5.1.1 Global Apomorphine Hydrochloride Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Apomorphine Hydrochloride Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Apomorphine Hydrochloride Revenue Market Share by Type (2021-2032)
- 5.2 Global Apomorphine Hydrochloride Sales by Type
- 5.2.1 Global Apomorphine Hydrochloride Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Apomorphine Hydrochloride Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Apomorphine Hydrochloride Sales Market Share by Type (2021-2032)
- 5.3 Global Apomorphine Hydrochloride Price by Type
6 Apomorphine Hydrochloride Market by Application
- 6.1 Global Apomorphine Hydrochloride Revenue by Application
- 6.1.1 Global Apomorphine Hydrochloride Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Apomorphine Hydrochloride Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Apomorphine Hydrochloride Revenue Market Share by Application (2021-2032)
- 6.2 Global Apomorphine Hydrochloride Sales by Application
- 6.2.1 Global Apomorphine Hydrochloride Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Apomorphine Hydrochloride Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Apomorphine Hydrochloride Sales Market Share by Application (2021-2032)
- 6.3 Global Apomorphine Hydrochloride Price by Application
7 Company Profiles
- 7.1 Supernus Pharmaceuticals
- 7.1.1 Supernus Pharmaceuticals Company Information
- 7.1.2 Supernus Pharmaceuticals Business Overview
- 7.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolio
- 7.1.5 Supernus Pharmaceuticals Recent Developments
- 7.2 Britannia Pharmaceuticals STADA
- 7.2.1 Britannia Pharmaceuticals STADA Company Information
- 7.2.2 Britannia Pharmaceuticals STADA Business Overview
- 7.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolio
- 7.2.5 Britannia Pharmaceuticals STADA Recent Developments
- 7.3 Ever Pharma
- 7.3.1 Ever Pharma Company Information
- 7.3.2 Ever Pharma Business Overview
- 7.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Ever Pharma Apomorphine Hydrochloride Product Portfolio
- 7.3.5 Ever Pharma Recent Developments
- 7.4 Evolan Pharma AB (PharmSwed)
- 7.4.1 Evolan Pharma AB (PharmSwed) Company Information
- 7.4.2 Evolan Pharma AB (PharmSwed) Business Overview
- 7.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolio
- 7.4.5 Evolan Pharma AB (PharmSwed) Recent Developments
- 7.5 Tianjin Tianwei Pharmaceutical
- 7.5.1 Tianjin Tianwei Pharmaceutical Company Information
- 7.5.2 Tianjin Tianwei Pharmaceutical Business Overview
- 7.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolio
- 7.5.5 Tianjin Tianwei Pharmaceutical Recent Developments
- 7.6 Sunovion
- 7.6.1 Sunovion Company Information
- 7.6.2 Sunovion Business Overview
- 7.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Sunovion Apomorphine Hydrochloride Product Portfolio
- 7.6.5 Sunovion Recent Developments
8 North America
- 8.1 North America Apomorphine Hydrochloride Market Size by Type
- 8.1.1 North America Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 8.1.2 North America Apomorphine Hydrochloride Sales by Type (2021-2032)
- 8.1.3 North America Apomorphine Hydrochloride Price by Type (2021-2032)
- 8.2 North America Apomorphine Hydrochloride Market Size by Application
- 8.2.1 North America Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 8.2.2 North America Apomorphine Hydrochloride Sales by Application (2021-2032)
- 8.2.3 North America Apomorphine Hydrochloride Price by Application (2021-2032)
- 8.3 North America Apomorphine Hydrochloride Market Size by Country
- 8.3.1 North America Apomorphine Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Apomorphine Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Apomorphine Hydrochloride Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Apomorphine Hydrochloride Market Size by Type
- 9.1.1 Europe Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 9.1.2 Europe Apomorphine Hydrochloride Sales by Type (2021-2032)
- 9.1.3 Europe Apomorphine Hydrochloride Price by Type (2021-2032)
- 9.2 Europe Apomorphine Hydrochloride Market Size by Application
- 9.2.1 Europe Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 9.2.2 Europe Apomorphine Hydrochloride Sales by Application (2021-2032)
- 9.2.3 Europe Apomorphine Hydrochloride Price by Application (2021-2032)
- 9.3 Europe Apomorphine Hydrochloride Market Size by Country
- 9.3.1 Europe Apomorphine Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Apomorphine Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Apomorphine Hydrochloride Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Apomorphine Hydrochloride Market Size by Type
- 10.1.1 China Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 10.1.2 China Apomorphine Hydrochloride Sales by Type (2021-2032)
- 10.1.3 China Apomorphine Hydrochloride Price by Type (2021-2032)
- 10.2 China Apomorphine Hydrochloride Market Size by Application
- 10.2.1 China Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 10.2.2 China Apomorphine Hydrochloride Sales by Application (2021-2032)
- 10.2.3 China Apomorphine Hydrochloride Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Apomorphine Hydrochloride Market Size by Type
- 11.1.1 Asia Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 11.1.2 Asia Apomorphine Hydrochloride Sales by Type (2021-2032)
- 11.1.3 Asia Apomorphine Hydrochloride Price by Type (2021-2032)
- 11.2 Asia Apomorphine Hydrochloride Market Size by Application
- 11.2.1 Asia Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 11.2.2 Asia Apomorphine Hydrochloride Sales by Application (2021-2032)
- 11.2.3 Asia Apomorphine Hydrochloride Price by Application (2021-2032)
- 11.3 Asia Apomorphine Hydrochloride Market Size by Country
- 11.3.1 Asia Apomorphine Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Apomorphine Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Apomorphine Hydrochloride Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Apomorphine Hydrochloride Market Size by Type
- 12.1.1 SAMEA Apomorphine Hydrochloride Revenue by Type (2021-2032)
- 12.1.2 SAMEA Apomorphine Hydrochloride Sales by Type (2021-2032)
- 12.1.3 SAMEA Apomorphine Hydrochloride Price by Type (2021-2032)
- 12.2 SAMEA Apomorphine Hydrochloride Market Size by Application
- 12.2.1 SAMEA Apomorphine Hydrochloride Revenue by Application (2021-2032)
- 12.2.2 SAMEA Apomorphine Hydrochloride Sales by Application (2021-2032)
- 12.2.3 SAMEA Apomorphine Hydrochloride Price by Application (2021-2032)
- 12.3 SAMEA Apomorphine Hydrochloride Market Size by Country
- 12.3.1 SAMEA Apomorphine Hydrochloride Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Apomorphine Hydrochloride Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Apomorphine Hydrochloride Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Apomorphine Hydrochloride Value Chain Analysis
- 13.1.1 Apomorphine Hydrochloride Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Apomorphine Hydrochloride Production Mode & Process
- 13.2 Apomorphine Hydrochloride Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Apomorphine Hydrochloride Distributors
- 13.2.3 Apomorphine Hydrochloride Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst